Literature DB >> 22494034

Cardiac involvement in hereditary-transthyretin related amyloidosis.

Claudio Rapezzi1, Simone Longhi, Agnese Milandri, Massimiliano Lorenzini, Christian Gagliardi, Ilaria Gallelli, Ornella Leone, Candida Cristina Quarta.   

Abstract

Hereditary transthyretin-related amyloidosis remains a widely underdiagnosed condition, owing to its extreme phenotypic variability: the clinical spectrum of the disease ranges from an almost exclusive neurologic involvement to strictly cardiac manifestations. This heterogeneity is linked to several factors including specific transthyretin mutations, geographic distribution and endemic vs. non-endemic aggregation type. The existence of exclusively or predominantly cardiac phenotypes makes the recognition of the disease very challenging since it can mimic other more common causes of left ventricular "hypertrophy". Assessment of such patients should include an active search for possible red flags that can indicate the correct final diagnosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22494034     DOI: 10.3109/13506129.2012.673185

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  3 in total

Review 1.  Noncerebral Amyloidoses: Aspects on Seeding, Cross-Seeding, and Transmission.

Authors:  Gunilla T Westermark; Marcus Fändrich; Katarzyna Lundmark; Per Westermark
Journal:  Cold Spring Harb Perspect Med       Date:  2018-01-02       Impact factor: 6.915

2.  Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area.

Authors:  Anna Mazzeo; Massimo Russo; Gianluca Di Bella; Fabio Minutoli; Claudia Stancanelli; Luca Gentile; Sergio Baldari; Scipione Carerj; Antonio Toscano; Giuseppe Vita
Journal:  J Neuromuscul Dis       Date:  2015-07-22

Review 3.  Multimodality Imaging in the Diagnosis and Assessment of Cardiac Amyloidosis.

Authors:  Jyothirmayi Velaga; Charlene Liew; Angeline Choo Choo Poh; Phong Teck Lee; Narayan Lath; Shoen Choon Low; Pushan Bharadwaj
Journal:  World J Nucl Med       Date:  2022-08-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.